Literature DB >> 3814929

Providing information to relatives about schizophrenia: some comments.

N Tarrier, C Barrowclough.   

Abstract

There has recently been an increased interest in providing relatives of schizophrenic patients with information about the illness and how to manage the patient at home, due partly to the development of psychosocial intervention programmes (which frequently include an educational component) and a consumer demand for such information in an era of community care. Studies which describe the effects of such educational programmes are reviewed, and two different models of information acquisition are contrasted. These models have different implications, in terms of outcome measures, on how educational programmes should be evaluated. Guidelines are offered for practitioners wishing to give information to relatives.

Entities:  

Mesh:

Year:  1986        PMID: 3814929     DOI: 10.1192/bjp.149.4.458

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  4 in total

1.  Educating relatives of schizophrenic patients.

Authors:  R Berkowitz; N Shavit; J P Leff
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1990-07       Impact factor: 4.328

2.  The role of relatives in discharge planning from psychiatric hospitals: the perspective of patients and their relatives.

Authors:  Michel Perreault; Hélène Tardif; Hélène Provencher; Geneviève Paquin; Julie Desmarais; Nicole Pawliuk
Journal:  Psychiatr Q       Date:  2005

3.  Staff-patient relationships in the care of the long-term adult mentally ill. A content analysis of Expressed Emotion interviews.

Authors:  E Moore; L Kuipers; R Ball
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-01       Impact factor: 4.328

4.  The Sydney intervention trial: a controlled trial of relatives' counselling to reduce schizophrenic relapse.

Authors:  K Vaughan; M Doyle; N McConaghy; A Blaszczynski; A Fox; N Tarrier
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1992-01       Impact factor: 4.328

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.